Article

Letter: Lebrikizumab for Refractory Atopic Dermatitis

Dermatitis
DOI: 10.1177/17103568251394379
0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Chalupczak, N. V., & Lio, P. (2025). Letter: Lebrikizumab for Refractory Atopic Dermatitis. Dermatitis. Mary Ann Liebert Inc. https://doi.org/10.1177/17103568251394379

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free